Recent Progress in Core-shell and Embedded Nanoparticle Technology for Biomarker Separation with Amperometric Sensing at a Boron Doped Diamond Electrode
Jeremy Glennon, University College Cork, speaking at European Lab Automation 2012
Towards a Disease-specific Biomarker Signature for Neuromuscular Disorders
Professor Kay Ohlendieck, National University of Ireland, speaking at Molecular Diagnostics Europe 2012.
Exploiting Carbon-Based Composites for Bacterial Threat Detection
Dr Duncan Sharp, Leeds Metropolitan University, speaking at Advances in Biodetection and Biosensors 2012.
Advances in the Synthesis and Analysis of Chiral Central Metabolites
Roland Wohlgemuth, Sigma-Aldrich, speaking at Advances in Metabolic Profiling 2011.
Metabolomic Biomarkers of Hypoxic Ischaemic Encephalopathy and Perinatal Asphyxia in Umbilical Cord Blood
Assistant Professor of Biostatistics, University of Alberta, speaking at Advances in Metabolic Profiling 2011.
Metabolites and Safety, the MIST and ICH-M3 GUIDANCE and their Impact on ADME
Gerhard Gross, Lundbeck Pharma, speaking at ADME & Predictive Toxicology Europe 2012
In Vitro, Ex Vivo and in Models to Develop New Therapies for Renal Diseases
Frederick W. K. Tam, Imperial College London, speaking at ADME & Predictive Toxicology Europe 2012
Biotransformation: Still a Bottleneck for in Vitro Kinetic and Dynamic Approaches
Sandra Coecke, European Centre for the Validation of Alternative Methods, speaking at ADME & Predictive Toxicology Europe
When is a Genotoxin not a Genotoxin?
Richard Walmsley, University of Manchester, speaking at ADME & Predictive Toxicology Europe